Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
20 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/20/2651112/0/en/Biostax-Corp-and-Statera-Biopharma-Inc-reach-mutually-beneficial-dispute-settlement-and-amended-license-agreement-providing-clearer-clinical-and-commercial-pathways-for-both-compan.html
15 Mar 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/03/15/2627590/0/en/Statera-Biopharma-Signs-Letter-of-Intent-for-Merger-with-Worksite-Labs.html
27 Oct 2022
// ACCESSWIRE
https://www.accesswire.com/722713/Statera-Biopharma-Receives-Positive-Nasdaq-Listing-Determination
21 Oct 2022
// ACCESSWIRE
https://www.accesswire.com/721696/Statera-Biopharma-Files-Form-10-Q-and-Reaches-Agreement-with-Silverback-Capital-and-AVOF
17 Oct 2022
// ACCESSWIRE
https://www.accesswire.com/720710/Statera-Biopharma-Announces-Signing-of-a-Binding-MOU-with-Holobeam-Technologies-to-Gain-Access-to-Holobeams-Disruptive-Diagnostic-Imaging-and-Therapeutic-Technology-for-Cancer-Patients
09 Sep 2022
// ACCESSWIRE
https://www.accesswire.com/715457/Statera-Biopharma-Receives-Nasdaq-Listing-Determination-Hearing-Requested-to-Address-Filing-Delinquency
ABOUT THIS PAGE